Miguel Rechichi1, Cosimo Mazzotta, Giovanni William Oliverio, Vito Romano, Davide Borroni, Marco Ferrise, Simone Bagaglia, Soosan Jacob, Alessandro Meduri. 1. From the Centro Polispecialistico Mediterraneo, Sellia Marina, Italy (Rechichi, Ferrise); Siena Crosslinking Center, Siena University Hospital, Ophthalmology Unit, Siena, Italy (Mazzotta, Bagaglia); Departement of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy (Oliverio, Meduri); Department of Ophthalmology, Royal Liverpool University Hospital, Liverpool, United Kingdom (Romano); Department of Ophthalmology, Riga Stradins University, Riga, Latvia (Borroni); Dr. Agarwal's Eye Hospital and Eye Research Centre, Chennai, India (Jacob).
Abstract
PURPOSE: To evaluate the changes in refractive outcomes and corneal aberrations in central and paracentral keratoconus after selective transepithelial topography-guided photorefractive keratectomy combined with accelerated corneal crosslinking (STARE-X). SETTINGS: Centro Polispecialistico Mediterraneo, Siena Crosslinking Center, and University of Messina, Italy. DESIGN: Prospective, interventional, multicentric study. METHODS: Patients were subdivided into 2 groups: Group 1 with cone located within the central 3 mm zone (50 eyes) and Group 2 (50 eyes) with cone located outside the central 3 mm zone. Follow-up was 2 years at least for all eyes. Outcome parameters included uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA). Corneal tomography and corneal wavefront aberrations were assessed and compared before and 2 years after the treatment. RESULTS: 100 eyes of 100 patients underwent STARE-X protocol. At 2 years, UDVA and CDVA improved, and sphere, cylinder, and Kmax reduced after treatment in both groups (P < .001, respectively). Moreover, a statistically significant reduction was observed of total higher-order aberrations root main square (RMS), coma RMS, and spherical aberration RMS in both groups (P < .001, respectively). However, CDVA improved more in Group 1 than in Group 2 (P < .02). CONCLUSIONS: The STARE-X protocol demonstrated effective results in halting keratoconus progression and improving corneal regularity with a safe and effective profile. STARE-X improved both visual acuity and corneal aberration at 2 years. Longer follow-up studies are warranted to observe further long-term CXL flattening effect on the cone.
PURPOSE: To evaluate the changes in refractive outcomes and corneal aberrations in central and paracentral keratoconus after selective transepithelial topography-guided photorefractive keratectomy combined with accelerated corneal crosslinking (STARE-X). SETTINGS: Centro Polispecialistico Mediterraneo, Siena Crosslinking Center, and University of Messina, Italy. DESIGN: Prospective, interventional, multicentric study. METHODS: Patients were subdivided into 2 groups: Group 1 with cone located within the central 3 mm zone (50 eyes) and Group 2 (50 eyes) with cone located outside the central 3 mm zone. Follow-up was 2 years at least for all eyes. Outcome parameters included uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA). Corneal tomography and corneal wavefront aberrations were assessed and compared before and 2 years after the treatment. RESULTS: 100 eyes of 100 patients underwent STARE-X protocol. At 2 years, UDVA and CDVA improved, and sphere, cylinder, and Kmax reduced after treatment in both groups (P < .001, respectively). Moreover, a statistically significant reduction was observed of total higher-order aberrations root main square (RMS), coma RMS, and spherical aberration RMS in both groups (P < .001, respectively). However, CDVA improved more in Group 1 than in Group 2 (P < .02). CONCLUSIONS: The STARE-X protocol demonstrated effective results in halting keratoconus progression and improving corneal regularity with a safe and effective profile. STARE-X improved both visual acuity and corneal aberration at 2 years. Longer follow-up studies are warranted to observe further long-term CXL flattening effect on the cone.
Authors: Cristina Ariadna Nicula; Adriana Elena Bulboacă; Dorin Nicula; Ariadna Patricia Nicula; Karin Ursula Horvath; Sorana D Bolboacă Journal: Front Med (Lausanne) Date: 2022-05-26
Authors: Neel S Vaidya; Arvin Daneshmand; Randy J Epstein; Parag A Majmudar; Michael W Belin; Edward C Parsons; Roy S Rubinfeld Journal: Clin Ophthalmol Date: 2022-06-08
Authors: Gavin Li; Laura Di Meglio; Jiangxia Wang; Fasika A Woreta; Kraig S Bower; Vishal Jhanji; Divya Srikumaran; Uri S Soiberman Journal: J Ophthalmol Date: 2022-06-01 Impact factor: 1.974
Authors: Rafael Vidal Merola; Sebastião Cronemberger; Artur William Veloso; Alberto Diniz-Filho Journal: Int J Ophthalmol Date: 2022-01-18 Impact factor: 1.779